Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Technologies to Acquire Genohm

NEW YORK (GenomeWeb) – Agilent Technologies announced late Wednesday that it has agreed to acquire privately held Genohm, a developer of on-premise and cloud-based laboratory management software.

Financial terms of the deal were not disclosed.

Genohm is headquartered in Lausanne, Switzerland, and has 40 employees. Its main laboratory software automation suite, SLIMS, is a digital platform that provides laboratories with a laboratory information management system (LIMS) and electronic lab notebook (ELN) environment that is used in biobanks, research labs, and next-generation sequencing facilities. The firm released version 6.0 of the software last August. The platform tracks data, samples, tests, users, results, and workflows from the original material shipments to the lab instruments and in silico analysis, Agilent said.

The firm also noted that the acquisition will enable it to add LIMS and workflow management to its own software offerings and expand its ELN capability and provide consumers with a single informatics solution across laboratory and operational domains.

"We were impressed with the team and the technology," John Sadler, vice president and general manager of Agilent's software and informatics division, said in a statement. "The modern architecture of SLIMS is perfectly aligned with the values of Agilent's OpenLab products. By integrating this technology with our broad and diverse instrument portfolio, we are in a unique position to support and enhance the operations of modern laboratories — truly helping our customers to do more with their data."

Kamni Vijay, vice president and general manager of Agilent's genomics division, added that the deal supports Agilent's "strategy to offer complete next-generation sequencing workflows and improve the laboratory management of our genomic customers."

This is Agilent's third acquisition in recent months. The firm said in March that it has signed a definitive agreement to acquire privately held Advanced Analytical Technologies for $250 million in cash, and that it would acquire the remaining shares of NGS technology firm Lasergen for $105 million.